肿瘤专家秘籍大公开:治肿瘤记住1234561

2017-06-16 陈小兵 健康时报网

明确“1个目标”那就是一定要努力活下来、活得好。因为只有活下来才是硬道理,俗话说得好“留得青山在不愁没柴烧”。坚持“2大手段”第一个手段是医生的治疗手段,得了肿瘤找对医生很重要,尤其是第一个医生(首诊首治医生),也不妨多走几个门诊听听不同医生的建议,再决定治疗方案;第二个手段是患者的自我康复手段(合理饮食、适量运动、戒烟戒酒、心态平衡、充足睡眠),要坚决与自己不良的生活习惯说再见。走好“3个阶段”

明确“1个目标”

那就是一定要努力活下来、活得好。因为只有活下来才是硬道理,俗话说得好“留得青山在不愁没柴烧”。

坚持“2大手段”

第一个手段是医生的治疗手段,得了肿瘤找对医生很重要,尤其是第一个医生(首诊首治医生),也不妨多走几个门诊听听不同医生的建议,再决定治疗方案;第二个手段是患者的自我康复手段(合理饮食、适量运动、戒烟戒酒、心态平衡、充足睡眠),要坚决与自己不良的生活习惯说再见。

走好“3个阶段”

第一阶段,尽可能地杀灭肿瘤,以攻(手术、放疗、化疗等)为主;第二阶段,使自己尽可能的恢复体力,特别是重建自身免疫和造血功能,攻补兼施;第三阶段,视情况再进行后续强化治疗。

坚持“4个相信”

相信科学,诊疗决策制定要科学化、规范化;相信医生,具体方案实施要个体化、人性化;相信自己,自我抗癌能量的释放要最大化、长期化;相信家人,病情交流沟通要透明化。

运用好“5大武器”

这5大武器主要是指手术、放疗、化疗、靶向或免疫治疗、中医药治疗等主要方法,这五大手段就像奥运五环一样,环环相扣。在治疗中,这五个手段常常联合使用。

注意“6大原则”:

原则一,局部与全身并重原则。若肿瘤发现的早,其治疗应以处理局部肿瘤为主,治疗多采用手术、放疗等,同时兼顾全身治疗;相反,若肿瘤发现的晚,失去手术根治的机会,其治疗应以全身治疗为主时,同时辅以局部治疗,往往能收到事半功倍的效果。

原则二,分期治疗原则。肿瘤分期不同,治疗方法也不同。以非小细胞肺癌为例:1、2期患者采用手术治疗,术后辅以化疗;3A期患者采用以手术为主的综合治疗,术前术后辅以化放疗;3B期、4期患者采用化疗、靶向治疗、免疫治疗为主的全身治疗。

原则三,个体化治疗原则。根据病人预期寿命、治疗耐受性、肿瘤异质性、基因检测结果等,为每一位患者“量体裁衣”制定最适合的治疗方案。以晚期胃肠癌为例,个体化治疗离不开基因检测,胃癌需检测HER-2表达,结直肠癌需检测K-ras、B-raf等基因。

原则四,生存率与生活质量并重原则。病人的预期寿命是否因治疗而延长?生活质量是否得到改善?从治疗开始就要坚持两手抓,一手抓“减瘤”(肿瘤治疗),一手抓“减症”(症状缓解),把镇痛、营养支持等姑息治疗融入抗肿瘤治疗的全程。

原则五,成本与效果并重原则。条条道路通罗马,有时候肿瘤的治疗路径并非一条。以局部晚期食管癌为例,临床上有多种治疗模式,如果临床效果基本一样的话,那么首选的是经济费用最低、患者生存时间和生活质量等受益最大的方案。

原则六,中西医结合并重原则。我国中医药源远流长,其中中药最大的长处就是在协助癌症患者身体康复上有一定疗效。如果中医运用得当,对巩固和加强肿瘤治疗效果,延长患者的生命时间、提高患者生存质量,都有一定益处。

“一体化治疗”

我国在逐步进入老龄化社会。据统计,60%的癌症发生在65岁以上的老年人身上,而且,老年肿瘤患者易并发心脑血管疾病、糖尿病、慢性阻塞性肺病等多种疾病。相对于单纯肿瘤患者,合并基础疾病老年肿瘤患者更为复杂。不仅需要肿瘤专家,还需要心血管病学、神经内科学等多方面的专科医生,进行多学科的综合治疗。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2185160, encodeId=5a41218516058, content=学习并收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f8811677, createdName=ms1000000799038861, createdTime=Thu Feb 01 00:21:58 CST 2024, time=2024-02-01, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2052810, encodeId=8774205281046, content=<a href='/topic/show?id=75c582e8226' target=_blank style='color:#2F92EE;'>#肿瘤专家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82782, encryptionId=75c582e8226, topicName=肿瘤专家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sun Oct 29 22:39:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213378, encodeId=328d2133e805, content=学习并收藏谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 21 07:49:20 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212170, encodeId=95042121e0bb, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/2d7b664549f24202a6267f7491207718/23a31240de2b44f8bf2fd2917c5b84d8.jpg, createdBy=662439212, createdName=yedu01, createdTime=Sun Jun 18 08:06:02 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212082, encodeId=cbdc21208236, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 18 01:16:53 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211945, encodeId=a92a21194568, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuEYA6ZJS2RZEJp0LgvdXH072EszfvD8xib0UGViaFO626UZIkB4ibvY1NicVJDFUSYoQjZvL6gnjziaYl/0, createdBy=48511932758, createdName=1e0d2fb7m34(暂无匿称), createdTime=Sat Jun 17 13:34:32 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211897, encodeId=c66a21189e21, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jun 17 10:36:58 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211662, encodeId=1120211662a6, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Jun 16 22:54:08 CST 2017, time=2017-06-16, status=1, ipAttribution=)]
    2024-02-01 ms1000000799038861 来自湖南省

    学习并收藏

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2185160, encodeId=5a41218516058, content=学习并收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f8811677, createdName=ms1000000799038861, createdTime=Thu Feb 01 00:21:58 CST 2024, time=2024-02-01, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2052810, encodeId=8774205281046, content=<a href='/topic/show?id=75c582e8226' target=_blank style='color:#2F92EE;'>#肿瘤专家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82782, encryptionId=75c582e8226, topicName=肿瘤专家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sun Oct 29 22:39:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213378, encodeId=328d2133e805, content=学习并收藏谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 21 07:49:20 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212170, encodeId=95042121e0bb, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/2d7b664549f24202a6267f7491207718/23a31240de2b44f8bf2fd2917c5b84d8.jpg, createdBy=662439212, createdName=yedu01, createdTime=Sun Jun 18 08:06:02 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212082, encodeId=cbdc21208236, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 18 01:16:53 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211945, encodeId=a92a21194568, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuEYA6ZJS2RZEJp0LgvdXH072EszfvD8xib0UGViaFO626UZIkB4ibvY1NicVJDFUSYoQjZvL6gnjziaYl/0, createdBy=48511932758, createdName=1e0d2fb7m34(暂无匿称), createdTime=Sat Jun 17 13:34:32 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211897, encodeId=c66a21189e21, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jun 17 10:36:58 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211662, encodeId=1120211662a6, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Jun 16 22:54:08 CST 2017, time=2017-06-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2185160, encodeId=5a41218516058, content=学习并收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f8811677, createdName=ms1000000799038861, createdTime=Thu Feb 01 00:21:58 CST 2024, time=2024-02-01, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2052810, encodeId=8774205281046, content=<a href='/topic/show?id=75c582e8226' target=_blank style='color:#2F92EE;'>#肿瘤专家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82782, encryptionId=75c582e8226, topicName=肿瘤专家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sun Oct 29 22:39:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213378, encodeId=328d2133e805, content=学习并收藏谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 21 07:49:20 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212170, encodeId=95042121e0bb, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/2d7b664549f24202a6267f7491207718/23a31240de2b44f8bf2fd2917c5b84d8.jpg, createdBy=662439212, createdName=yedu01, createdTime=Sun Jun 18 08:06:02 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212082, encodeId=cbdc21208236, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 18 01:16:53 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211945, encodeId=a92a21194568, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuEYA6ZJS2RZEJp0LgvdXH072EszfvD8xib0UGViaFO626UZIkB4ibvY1NicVJDFUSYoQjZvL6gnjziaYl/0, createdBy=48511932758, createdName=1e0d2fb7m34(暂无匿称), createdTime=Sat Jun 17 13:34:32 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211897, encodeId=c66a21189e21, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jun 17 10:36:58 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211662, encodeId=1120211662a6, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Jun 16 22:54:08 CST 2017, time=2017-06-16, status=1, ipAttribution=)]
    2017-06-21 大爰

    学习并收藏谢谢分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2185160, encodeId=5a41218516058, content=学习并收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f8811677, createdName=ms1000000799038861, createdTime=Thu Feb 01 00:21:58 CST 2024, time=2024-02-01, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2052810, encodeId=8774205281046, content=<a href='/topic/show?id=75c582e8226' target=_blank style='color:#2F92EE;'>#肿瘤专家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82782, encryptionId=75c582e8226, topicName=肿瘤专家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sun Oct 29 22:39:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213378, encodeId=328d2133e805, content=学习并收藏谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 21 07:49:20 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212170, encodeId=95042121e0bb, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/2d7b664549f24202a6267f7491207718/23a31240de2b44f8bf2fd2917c5b84d8.jpg, createdBy=662439212, createdName=yedu01, createdTime=Sun Jun 18 08:06:02 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212082, encodeId=cbdc21208236, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 18 01:16:53 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211945, encodeId=a92a21194568, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuEYA6ZJS2RZEJp0LgvdXH072EszfvD8xib0UGViaFO626UZIkB4ibvY1NicVJDFUSYoQjZvL6gnjziaYl/0, createdBy=48511932758, createdName=1e0d2fb7m34(暂无匿称), createdTime=Sat Jun 17 13:34:32 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211897, encodeId=c66a21189e21, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jun 17 10:36:58 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211662, encodeId=1120211662a6, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Jun 16 22:54:08 CST 2017, time=2017-06-16, status=1, ipAttribution=)]
    2017-06-18 yedu01

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2185160, encodeId=5a41218516058, content=学习并收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f8811677, createdName=ms1000000799038861, createdTime=Thu Feb 01 00:21:58 CST 2024, time=2024-02-01, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2052810, encodeId=8774205281046, content=<a href='/topic/show?id=75c582e8226' target=_blank style='color:#2F92EE;'>#肿瘤专家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82782, encryptionId=75c582e8226, topicName=肿瘤专家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sun Oct 29 22:39:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213378, encodeId=328d2133e805, content=学习并收藏谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 21 07:49:20 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212170, encodeId=95042121e0bb, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/2d7b664549f24202a6267f7491207718/23a31240de2b44f8bf2fd2917c5b84d8.jpg, createdBy=662439212, createdName=yedu01, createdTime=Sun Jun 18 08:06:02 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212082, encodeId=cbdc21208236, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 18 01:16:53 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211945, encodeId=a92a21194568, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuEYA6ZJS2RZEJp0LgvdXH072EszfvD8xib0UGViaFO626UZIkB4ibvY1NicVJDFUSYoQjZvL6gnjziaYl/0, createdBy=48511932758, createdName=1e0d2fb7m34(暂无匿称), createdTime=Sat Jun 17 13:34:32 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211897, encodeId=c66a21189e21, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jun 17 10:36:58 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211662, encodeId=1120211662a6, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Jun 16 22:54:08 CST 2017, time=2017-06-16, status=1, ipAttribution=)]
    2017-06-18 luominglian113

    学习了,谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2185160, encodeId=5a41218516058, content=学习并收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f8811677, createdName=ms1000000799038861, createdTime=Thu Feb 01 00:21:58 CST 2024, time=2024-02-01, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2052810, encodeId=8774205281046, content=<a href='/topic/show?id=75c582e8226' target=_blank style='color:#2F92EE;'>#肿瘤专家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82782, encryptionId=75c582e8226, topicName=肿瘤专家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sun Oct 29 22:39:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213378, encodeId=328d2133e805, content=学习并收藏谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 21 07:49:20 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212170, encodeId=95042121e0bb, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/2d7b664549f24202a6267f7491207718/23a31240de2b44f8bf2fd2917c5b84d8.jpg, createdBy=662439212, createdName=yedu01, createdTime=Sun Jun 18 08:06:02 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212082, encodeId=cbdc21208236, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 18 01:16:53 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211945, encodeId=a92a21194568, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuEYA6ZJS2RZEJp0LgvdXH072EszfvD8xib0UGViaFO626UZIkB4ibvY1NicVJDFUSYoQjZvL6gnjziaYl/0, createdBy=48511932758, createdName=1e0d2fb7m34(暂无匿称), createdTime=Sat Jun 17 13:34:32 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211897, encodeId=c66a21189e21, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jun 17 10:36:58 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211662, encodeId=1120211662a6, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Jun 16 22:54:08 CST 2017, time=2017-06-16, status=1, ipAttribution=)]
    2017-06-17 1e0d2fb7m34(暂无匿称)

    总结的很好!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2185160, encodeId=5a41218516058, content=学习并收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f8811677, createdName=ms1000000799038861, createdTime=Thu Feb 01 00:21:58 CST 2024, time=2024-02-01, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2052810, encodeId=8774205281046, content=<a href='/topic/show?id=75c582e8226' target=_blank style='color:#2F92EE;'>#肿瘤专家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82782, encryptionId=75c582e8226, topicName=肿瘤专家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sun Oct 29 22:39:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213378, encodeId=328d2133e805, content=学习并收藏谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 21 07:49:20 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212170, encodeId=95042121e0bb, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/2d7b664549f24202a6267f7491207718/23a31240de2b44f8bf2fd2917c5b84d8.jpg, createdBy=662439212, createdName=yedu01, createdTime=Sun Jun 18 08:06:02 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212082, encodeId=cbdc21208236, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 18 01:16:53 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211945, encodeId=a92a21194568, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuEYA6ZJS2RZEJp0LgvdXH072EszfvD8xib0UGViaFO626UZIkB4ibvY1NicVJDFUSYoQjZvL6gnjziaYl/0, createdBy=48511932758, createdName=1e0d2fb7m34(暂无匿称), createdTime=Sat Jun 17 13:34:32 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211897, encodeId=c66a21189e21, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jun 17 10:36:58 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211662, encodeId=1120211662a6, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Jun 16 22:54:08 CST 2017, time=2017-06-16, status=1, ipAttribution=)]
    2017-06-17 ylzr123

    认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2185160, encodeId=5a41218516058, content=学习并收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6f8811677, createdName=ms1000000799038861, createdTime=Thu Feb 01 00:21:58 CST 2024, time=2024-02-01, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2052810, encodeId=8774205281046, content=<a href='/topic/show?id=75c582e8226' target=_blank style='color:#2F92EE;'>#肿瘤专家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82782, encryptionId=75c582e8226, topicName=肿瘤专家)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Sun Oct 29 22:39:00 CST 2017, time=2017-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=213378, encodeId=328d2133e805, content=学习并收藏谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Jun 21 07:49:20 CST 2017, time=2017-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212170, encodeId=95042121e0bb, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/2d7b664549f24202a6267f7491207718/23a31240de2b44f8bf2fd2917c5b84d8.jpg, createdBy=662439212, createdName=yedu01, createdTime=Sun Jun 18 08:06:02 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212082, encodeId=cbdc21208236, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jun 18 01:16:53 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211945, encodeId=a92a21194568, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuEYA6ZJS2RZEJp0LgvdXH072EszfvD8xib0UGViaFO626UZIkB4ibvY1NicVJDFUSYoQjZvL6gnjziaYl/0, createdBy=48511932758, createdName=1e0d2fb7m34(暂无匿称), createdTime=Sat Jun 17 13:34:32 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211897, encodeId=c66a21189e21, content=认真学习,把间接经验应用到临床实践中去,然后再总结出新思路。给点赞啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sat Jun 17 10:36:58 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211662, encodeId=1120211662a6, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Fri Jun 16 22:54:08 CST 2017, time=2017-06-16, status=1, ipAttribution=)]
    2017-06-16 thlabcde

    好东西学习了!

    0

相关资讯

肿瘤:预防胜治疗

  很多人一提起癌症都会为之色变,如果癌症不幸降临到自己头上,或是长了肿瘤,更是好像被宣判了死刑,整天处在恐慌之中。有一种说法是癌症病人都是被吓死的,但究竟什么是肿瘤?什么是癌症?你了解癌症多少?   恶性肿瘤就是癌症   “恶性肿瘤就是癌症”这是肿瘤专家给出的最通俗易懂的答案。肿瘤分为良性肿瘤和恶性肿瘤,一般所说的癌即指恶性肿瘤。   专家告诉记者,癌细胞的特点就是无限制、无止境地增生,使

甲状腺癌患者最想知道的,名肿瘤专家全告诉你!

采访专家高明:天津市肿瘤医院副院长,甲状腺肿瘤科主任医师,中国抗癌协会甲状腺癌专业委员会主任委员。擅长:头颈部常见肿瘤的诊治及常见外科术式,特别对功能性和微创甲状腺外科,以及中晚期甲状腺癌、全喉及各种部分喉切除手术等。出诊时间:每周五上午。周晓红:重庆市肿瘤医院头颈外科主任,中国抗癌协会头颈专委会委员、中国抗癌协会甲状腺专业委员会委员;擅长:头颈肿瘤的综合治疗,包括甲状腺肿瘤微创及甲状腺恶性肿